The European Union is at a critical point in addressing its growing mental health crisis. Even before the Covid-19 pandemic, nearly 84 million people in the EU lived with mental health conditions, including serious mental health illnesses such as schizophrenia and major depression. The economic cost is staggering – an estimated €600bn annually – but the human cost, marked by stigma, discrimination, and inadequate care, is incalculable.
The pandemic has worsened these challenges, pushing the EU to act. In June 2023, the European Commission adopted a communication to support member states in achieving a comprehensive approach to mental health. This initiative aims to reduce stigma, improve access to treatment and support recovery. While the plan is a step forward, more comprehensive action is needed to fully address the crisis.
Tackling stigma is crucial. Misunderstanding and prejudice often prevent people from seeking help. Campaigns like Denmark’s “One of us” have shown that public education can shift attitudes by focusing on real-life experiences. The EU has pledged €18m toward anti-stigma campaigns, but treating mental health with the same importance as physical health requires further efforts.
Access to mental health care is another major issue, with services unevenly distributed across Europe and a shortage of professionals. Many patients rely on general practitioners for psychiatric care, even though they often lack specialised training. Europe must expand its mental health workforce and better integrate mental health into general healthcare services.
A comprehensive EU mental health strategy is essential – one that prioritises prevention, treatment, and care while addressing social factors that affect mental health. National strategies should go beyond healthcare and include areas, like social services, employment and education. Improving data collection is also key to ensuring evidence-based care. A shift toward community-based mental health care offers a more sustainable solution, as personalised, local services can better meet individual needs.
At Boehringer Ingelheim, we are striving to make sure that every individual impacted by serious mental illnesses can thrive. We have made a long-term commitment to invest in research with the aspiration of redefining mental healthcare in partnership with multiple stakeholders. Together, we can build healthier, resilient societies across Europe.